Your browser doesn't support javascript.
loading
Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency.
Le Voyer, Tom; Sakata, Sonoko; Tsumura, Miyuki; Khan, Taushif; Esteve-Sole, Ana; Al-Saud, Bandar K; Gungor, Hatice Eke; Taur, Prasad; Jeanne-Julien, Valentine; Christiansen, Mette; Köhler, Lisa-Maria; ElGhazali, Gehad Eltayeb; Rosain, Jérémie; Nishimura, Shiho; Sakura, Fumiaki; Bouaziz, Matthieu; Oleaga-Quintas, Carmen; Nieto-Patlán, Alejandro; Deyà-Martinez, Àngela; Altuner Torun, Yasemin; Neehus, Anna-Lena; Roynard, Manon; Bozdemir, Sefika Elmas; Al Kaabi, Nawal; Al Hassani, Moza; Mersiyanova, Irina; Rozenberg, Flore; Speckmann, Carsten; Hainmann, Ina; Hauck, Fabian; Alzahrani, Mohammed Hamdan; Alhajjar, Sami Hussain; Al-Muhsen, Saleh; Cole, Theresa; Fuleihan, Ramsay; Arkwright, Peter D; Badolato, Raffaele; Alsina, Laia; Abel, Laurent; Desai, Mukesh; Al-Mousa, Hamoud; Shcherbina, Anna; Marr, Nico; Boisson-Dupuis, Stéphanie; Casanova, Jean-Laurent; Okada, Satoshi; Bustamante, Jacinta.
Afiliación
  • Le Voyer T; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France; jacinta.bustamante@inserm.fr levoyertom@gmail.com.
  • Sakata S; University of Paris, Imagine Institute, Paris, France.
  • Tsumura M; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Khan T; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Esteve-Sole A; Division of Translational Medicine, Sidra Medicine, Doha, Qatar.
  • Al-Saud BK; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, and Functional Unit of Immunology, Sant Joan de Déu Hospital, Institut de Recerca Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Gungor HE; Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Taur P; Department of Pediatrics, Pediatric Allergy and Immunology Unit, Kayseri Education and Research Hospital, Erkilet, Kayseri, Turkey.
  • Jeanne-Julien V; Department of Pediatric Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India.
  • Christiansen M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Köhler LM; University of Paris, Imagine Institute, Paris, France.
  • ElGhazali GE; Department of Clinical Immunology, Aarhus University Hospital, Aarhus N, Denmark.
  • Rosain J; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Nishimura S; Sheikh Khalifa Medical City-Union71, Abu Dhabi and Department of Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Sakura F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Bouaziz M; University of Paris, Imagine Institute, Paris, France.
  • Oleaga-Quintas C; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Nieto-Patlán A; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Deyà-Martinez À; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Altuner Torun Y; University of Paris, Imagine Institute, Paris, France.
  • Neehus AL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Roynard M; University of Paris, Imagine Institute, Paris, France.
  • Bozdemir SE; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Al Kaabi N; University of Paris, Imagine Institute, Paris, France.
  • Al Hassani M; Research and Development in Bioprocess Unit, National School of Biological Sciences, National Polytechnic Institute, Mexico City, Mexico.
  • Mersiyanova I; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, and Functional Unit of Immunology, Sant Joan de Déu Hospital, Institut de Recerca Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
  • Rozenberg F; Pediatric Hematology and Oncology Unit, Istinye University, School of Medicine, Istanbul, Turkey.
  • Speckmann C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Hainmann I; University of Paris, Imagine Institute, Paris, France.
  • Hauck F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France.
  • Alzahrani MH; University of Paris, Imagine Institute, Paris, France.
  • Alhajjar SH; Pediatric Infectious Disease Unit, Department of Pediatrics, Kayseri Education and Research Hospital, Erkilet, Kayseri, Turkey.
  • Al-Muhsen S; Sheikh Khalifa Medical City-Union71, Abu Dhabi and Department of Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Cole T; Sheikh Khalifa Medical City-Union71, Abu Dhabi and Department of Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Fuleihan R; Molecular Biology Laboratory, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Arkwright PD; Department of Virology, Cochin Hospital, University of Paris, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Badolato R; Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Alsina L; Center for Chronic Immunodeficiency, Institute for Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Abel L; Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Desai M; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Al-Mousa H; Pediatric Department, Security Forces Hospital, Riyadh, Saudi Arabia.
  • Shcherbina A; Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Marr N; Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Boisson-Dupuis S; Immunology Research Laboratory, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Casanova JL; Department of Immunology, The Royal Children's Hospital, Melbourne, Australia.
  • Okada S; Division of Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
  • Bustamante J; Department of Paediatric Allergy and Immunology, Lydia Becker Institute of Immunology and Inflammation, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom.
J Immunol ; 207(1): 133-152, 2021 07 01.
Article en En | MEDLINE | ID: mdl-34183371
ABSTRACT
Autosomal recessive (AR) STAT1 deficiency is a severe inborn error of immunity disrupting cellular responses to type I, II, and III IFNs, and IL-27, and conferring a predisposition to both viral and mycobacterial infections. We report the genetic, immunological, and clinical features of an international cohort of 32 patients from 20 kindreds 24 patients with complete deficiency, and 8 patients with partial deficiency. Twenty-four patients suffered from mycobacterial disease (bacillus Calmette-Guérin = 13, environmental mycobacteria = 10, or both in 1 patient). Fifty-four severe viral episodes occurred in sixteen patients, mainly caused by Herpesviridae viruses. Attenuated live measles, mumps, and rubella and/or varicella zoster virus vaccines triggered severe reactions in the five patients with complete deficiency who were vaccinated. Seven patients developed features of hemophagocytic syndrome. Twenty-one patients died, and death was almost twice as likely in patients with complete STAT1 deficiency than in those with partial STAT1 deficiency. All but one of the eight survivors with AR complete deficiency underwent hematopoietic stem cell transplantation. Overall survival after hematopoietic stem cell transplantation was 64%. A diagnosis of AR STAT1 deficiency should be considered in children with mycobacterial and/or viral infectious diseases. It is important to distinguish between complete and partial forms of AR STAT1 deficiency, as their clinical outcome and management differ significantly.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfohistiocitosis Hemofagocítica / Mycobacterium bovis / Infecciones por Mycobacterium Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfohistiocitosis Hemofagocítica / Mycobacterium bovis / Infecciones por Mycobacterium Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article